drugset / Trial / NCT04139395
68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
NaSingle-groupOpen-labelDiagnostic
Summary
This is a Phase III study to evaluate 68Ga Citrate PET/MRI for detection of origin of fever of unknown origin.
Timeline
- Start
- 2019-01-15
- Primary completion
- 2020-12-20
- Completion
- 2021-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 67Ga-Citrate | Diagnostic / imaging agent | — | — |
| Subject | 68Ga-citrate | Diagnostic / imaging agent | 370 mbq | Intravenous |